BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27932055)

  • 1. Understanding women's hesitancy to undergo less frequent cervical cancer screening.
    Gerend MA; Shepherd MA; Kaltz EA; Davis WJ; Shepherd JE
    Prev Med; 2017 Feb; 95():96-102. PubMed ID: 27932055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.
    Meissner HI; Tiro JA; Yabroff KR; Haggstrom DA; Coughlin SS
    Med Care; 2010 Mar; 48(3):249-59. PubMed ID: 20182268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
    Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
    Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).
    Nelson W; Moser RP; Gaffey A; Waldron W
    J Womens Health (Larchmt); 2009 Nov; 18(11):1759-68. PubMed ID: 19951209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
    Malo TL; Perkins RB; Lee JH; Vadaparampil ST
    Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
    Berkowitz Z; Nair N; Saraiya M
    Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
    Hallett LD; Gerber MR
    J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA.
    Reiter PL; McRee AL
    J Fam Plann Reprod Health Care; 2015 Oct; 41(4):259-64. PubMed ID: 25385868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
    Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
    J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
    Perkins RB; Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Michel A; Whitmer A; Vadaparampil ST
    Womens Health Issues; 2024; 34(3):257-267. PubMed ID: 38383228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
    AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality.
    Saraiya M; Kwan A; Cooper CP
    Prev Med; 2018 Mar; 108():111-114. PubMed ID: 29277414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women.
    Suarez L; Pulley L
    J Natl Cancer Inst Monogr; 1995; (18):41-7. PubMed ID: 8562221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.